Chubb Limited (CB)
(Real Time Quote from BATS)
$267.61 USD
-0.39 (-0.15%)
Updated Aug 13, 2024 03:53 PM ET
After-Market: $267.88 +0.27 (0.10%) 4:14 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$267.61 USD
-0.39 (-0.15%)
Updated Aug 13, 2024 03:53 PM ET
After-Market: $267.88 +0.27 (0.10%) 4:14 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Zacks News
Chubb Limited was formerly known as ACE Limited. ACE Limited after acquiring The Chubb Corp in Jan 2016 assumed the name of Chubb. Headquartered in Zurich, Switzerland, the company boasts being one of the world’s largest providers of property and casualty (P&C) insurance and reinsurance and largest publicly traded P&C insurer, based on market capitalization of $56.9 billion. Chubb has diversified through acquisitions into many specialty lines, including marine, medical risk, excess property, environmental and terrorism insurance and has local operations in 54 countries and territories. Chubb provides specialized insurance products such as personal accident, supplemental health and life insurance to individuals in select countries. Its reinsurance operations include both P&C and life companies.
Travelers' (TRV) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Travelers' (TRV) Q3 earnings reflect higher net written premiums, improved combined ratio and higher underwriting gain, partially offset by lower net investment income and higher expenses.
Arch Capital Group (ACGL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Arch Capital (ACGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Should You Add Chubb (CB) Stock to Your Portfolio
by Zacks Equity Research
A compelling portfolio, strong renewal retention, positive rate increases, strategic initiatives to fuel profitability and solid capital position poise Chubb (CB) for growth.
Chubb (CB) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Chubb (CB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Investors Undervaluing Chubb Limited (CB) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Progressive (PGR) Q3 Earnings Lag Estimates, Premiums Rise Y/Y
by Zacks Equity Research
Progressive's (PGR) Q3 earnings reflect improvement in the top line, offset by higher expenses.
Top Stock Reports for JPMorgan Chase, T-Mobile US & SAP
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), T-Mobile US, Inc. (TMUS) and SAP SE (SAP).
PGR or CB: Which P&C Insurance Stock is Better Placed?
by Zacks Equity Research
Let's see how Chubb (CB) and Progressive (PGR) fare in terms of some of the key metrics.
Should You Invest in the iShares U.S. Insurance ETF (IAK)?
by Zacks Equity Research
Sector ETF report for IAK
CB vs. CCCS: Which Stock Is the Better Value Option?
by Zacks Equity Research
CB vs. CCCS: Which Stock Is the Better Value Option?
Why Should You Retain Cigna (CI) in Your Portfolio Now?
by Zacks Equity Research
Cigna (CI) is aided by powerful segmental performances, solid demand for its Medicare plans, divestitures and solid cash-generating abilities.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Chubb Limited (CB) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should You Invest in the Invesco KBW Property & Casualty Insurance ETF (KBWP)?
by Zacks Equity Research
Sector ETF report for KBWP
Chubb (CB) Gains 9% in a Year: More Room for Upside Left?
by Zacks Equity Research
A compelling portfolio, strong renewal retention, positive rate increases, strategic initiatives to fuel profitability and solid capital position continue to drive Chubb (CB).
Allstate's (ALL) Auto Rate Hiking Spree Continues in August
by Zacks Equity Research
Allstate (ALL) raises auto rates in August to offset headwinds stemming from inflationary pressures.
Three Dividend Aristocrat Stocks for Investors to Consider
by Shaun Pruitt
A look at three dividend Aristocrats that also have good growth prospects, most notably in rising earnings estimates.
Should Value Investors Buy Chubb Limited (CB) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is CaixaBank (CAIXY) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how CaixaBank, S.A. Unsponsored ADR (CAIXY) and Chubb (CB) have performed compared to their sector so far this year.
3 Value Stocks to Bet on From Undervalued P&C Insurance Space
by Zacks Equity Research
Leveraging improved pricing, increased technology advancements, underwriting profitability and global expansion and an impressive solvency level, undervalued P&C insurers like ACGL, CB, WRB are poised to fetch better returns.
Bet on These 5 Low-Leverage Stocks as Inflation Looms Large
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may buy TITN, VLO, CB, KRG & SATS
Selective Insurance (SIGI) Up 5.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Selective Insurance (SIGI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights Exxon Mobil, Marsh & McLennan, Chubb, CrowdStrike and Cheniere
by Zacks Equity Research
Exxon Mobil, Marsh & McLennan, Chubb, CrowdStrike and Cheniere are part of The Zacks top Analyst Blog.
Top Research Reports for Exxon Mobil, Marsh & McLennan & Chubb
by Zacks Equity Research
Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), Marsh & McLennan Companies, Inc. (MMC) and Chubb Limited (CB).
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.